rheumatology
Bone health

Slow progress in building clinical utility of bone turnover markers

Bone turnover markers have “potential” to provide clinically useful information in the treatment of osteoporosis but their utility continues to be hampered by problems including an inconsistent association with fracture risk and wide variations in assays. International experts, including Professor Howard Morris from the University of Adelaide and Dr Sam Vasikaran from the Fiona Stanley ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic